drugset / Trial / NCT03887208
Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells
Phase 1/2
Completed
100 enrolled
Medical University of Warsaw
Melitus sp. z o.o. · collabPolish Stem Cells Bank S.A. · collabTimeless Chirurgia Plastyczna-Janusz Jaworowski · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to compare clinical outcomes of patients with large scars or Cutis laxa treated with injections of autologous stromal vascular fraction cells (SVF) and adipose-derived mesenchymal stem cells (ADSC).
Timeline
- Start
- 2018-01-31
- Primary completion
- 2020-01-18
- Completion
- 2020-01-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | adipose-derived mesenchymal stem cells | Cell therapy | — | Subcutaneous |